210 related articles for article (PubMed ID: 26369655)
1. Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study.
Han X; Jiang K; Wang B; Zhou L; Chen X; Li S
Clin Drug Investig; 2015 Oct; 35(10):665-73. PubMed ID: 26369655
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice.
Hahm KB; Kim DH; Lee KM; Lee JS; Surh YJ; Kim YB; Yoo BM; Kim JH; Joo HJ; Cho YK; Nam KT; Cho SW
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():24-38. PubMed ID: 12925138
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter PyloriAssociation with Expression of CDX2 in Intestinal Metaplasia.
Malik TH; WangYu ; XuHong
J Coll Physicians Surg Pak; 2017 Nov; 27(11):678-681. PubMed ID: 29132476
[TBL] [Abstract][Full Text] [Related]
4. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
5. Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia.
Shiotani A; Uedo N; Iishi H; Tatsuta M; Ishiguro S; Nakae Y; Kamada T; Haruma K; Merchant JL
Int J Cancer; 2007 Sep; 121(6):1182-9. PubMed ID: 17520681
[TBL] [Abstract][Full Text] [Related]
6. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
7. Determinants of gastric CDX2 expression: a study in Mozambique.
Peleteiro B; Barros R; Carrilho C; Artiaga J; Cunha L; Modcoicar P; Ferreira R; Figueiredo C; Almeida R; La Vecchia C; David L; Barros H; Lunet N
Eur J Cancer Prev; 2012 Nov; 21(6):532-40. PubMed ID: 22407102
[TBL] [Abstract][Full Text] [Related]
8. An open-labeled study of rebamipide treatment in chronic gastritis patients with dyspeptic symptoms refractory to proton pump inhibitors.
Chitapanarux T; Praisontarangkul OA; Lertprasertsuke N
Dig Dis Sci; 2008 Nov; 53(11):2896-903. PubMed ID: 18452057
[TBL] [Abstract][Full Text] [Related]
9. Expression of CDX2 and villin in gastric cardiac intestinal metaplasia and the relation with gastric cardiac carcinogenesis.
Xiao ZY; Ru Y; Sun JT; Gao SG; Wang YF; Wang LD; Feng XS
Asian Pac J Cancer Prev; 2012; 13(1):247-50. PubMed ID: 22502678
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of rebamipide according to Helicobacter pylori status in patients with chronic erosive gastritis: a randomized sucralfate-controlled multicenter trial in China-STARS study.
Du Y; Li Z; Zhan X; Chen J; Gao J; Gong Y; Ren J; He L; Zhang Z; Guo X; Wu J; Tian Z; Shi R; Jiang B; Fang D; Li Y
Dig Dis Sci; 2008 Nov; 53(11):2886-95. PubMed ID: 18288617
[TBL] [Abstract][Full Text] [Related]
11. Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression.
Ierardi E; Francavilla A; Balzano T; Traversa A; Principi M; Monno RA; Amoruso A; Ingrosso M; Pisani A; Panella C
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):214-9. PubMed ID: 9646212
[TBL] [Abstract][Full Text] [Related]
12. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M
Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824
[TBL] [Abstract][Full Text] [Related]
13. Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype.
Cassaro M; Rugge M; Tieppo C; Giacomelli L; Velo D; Nitti D; Farinati F
J Clin Pathol; 2007 Jun; 60(6):615-21. PubMed ID: 17557866
[TBL] [Abstract][Full Text] [Related]
14. The combined presence of H pylori infection and gastro-oesophageal reflux disease leads to an up-regulation of CDX2 gene expression in antrum and cardia.
Bornschein J; Wex T; Peitz U; Kuester D; Roessner A; Malfertheiner P
J Clin Pathol; 2009 Mar; 62(3):254-9. PubMed ID: 19251954
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils.
Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Tatsuguchi A; Ueki N; Shinji Y; Kusunoki M; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
Digestion; 2006; 74(3-4):187-98. PubMed ID: 17341852
[TBL] [Abstract][Full Text] [Related]
16. Rebamipide for the Improvement of Gastric Atrophy and Intestinal Metaplasia: A Prospective, Randomized, Pilot Study.
Lee JS; Jeon SW; Lee HS; Kwon YH; Nam SY; Bae HI; Seo AN
Dig Dis Sci; 2022 Jun; 67(6):2395-2402. PubMed ID: 34052947
[TBL] [Abstract][Full Text] [Related]
17. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
Nasser SC; Slim M; Nassif JG; Nasser SM
World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of trefoil factor 3 as a non-invasive biomarker of gastric intestinal metaplasia and gastric cancer in a high-risk population.
Latorre G; Pizarro M; Ford JS; Gándara V; Muñoz G; Araya JC; Bellolio E; Villaseca M; Fuentes-López E; Cortés P; Rollán A; Bufadel ME; Araya R; Vargas JI; Espino A; Sharp A; Agüero C; Donoso A; Bresky G; Pedrero P; Rueda C; Calvo A; Odagaki T; Moriyama T; Ishida T; Parra-Blanco A; Camargo MC; González R; Corvalán AH; Riquelme A;
Gastroenterol Hepatol; 2023; 46(6):411-418. PubMed ID: 35580739
[TBL] [Abstract][Full Text] [Related]
19. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori eradication prevents extension of intestinalization even in the high-risk group for gastric cancer.
Shiotani A; Nishi R; Uedo N; Iishi H; Tsutsui H; Ishii M; Imamura H; Kamada T; Hata J; Haruma K
Digestion; 2010; 81(4):223-30. PubMed ID: 20110706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
